NeuroOne Medical Technologies Corporation Common Stock (NMTC)
Stock · NASDAQ · Health Care
$0.961as of 10/16/2026
Price chart
NMTC Signal Track Record
How signals performed across all stocks →What NMTC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 45 | -4.7% | 38% | September 29, 2026 |
| 200-Day Moving Average TouchActive now | 23 | -8.8% | 30% | May 8, 2026 |
| Bollinger Band Breakdown | 19 | -0.9% | 47% | September 29, 2026 |
| Bollinger Band Breakout | 19 | -5.8% | 42% | August 19, 2026 |
| Any 20-session window (baseline) | -3.2% | 43% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NMTC
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia,…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 18
- Website
- nmtc1.com/
Fundamentals
- 1-day range
- $1.07$1.12
- Market cap
- $13.36M
- P/E (trailing)
- —
- P/E (forward)
- -3.86
- EPS (trailing)
- $-0.84
- Dividend yield
- —
- Beta
- 0.93
- Avg. volume
- 335.4K
How NeuroOne Medical Technologies Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Dec 17, 2025 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
NeuroOne Medical Technologies Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- NMTCNeuroOne Medical Technologies Corporation Common Stock$0.961▼ 7.60%Market cap $13.36MP/E —$0.9615$6.96
- ICUSeaStar Medical Holding Corporation Common Stock$2.9▼ 5.23%Market cap $12.19MP/E —$2.07$7.35
- AMIXAutonomix Medical Inc. Common Stock$2.85▼ 2.90%Market cap $11.82MP/E —$2.44$32.55
- OSRHOSR Health Inc. Common Stock$0.226▲ 13.00%Market cap $15.32MP/E 12.44$0.075$0.9078
- MODDModular Medical Inc. Common Stock$2.32▲ 7.18%Market cap $10.99MP/E —$1.72$18.76
- MDAIWSpectral AI Inc. Warrants$0.445▲ 8.54%Market cap $15.91MP/E —$0.355$1.01
- ICCMIceCure Medical Ltd. Ordinary Shares$1.06▲ 1.92%Market cap $10.55MP/E —$1.04$29.46
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NMTC NeuroOne Medical Technologies Corporation Common Stock | $13.36M | — | $0.961 | ▼ 7.60% | $0.9615$6.96 |
| ICU SeaStar Medical Holding Corporation Common Stock | $12.19M | — | $2.9 | ▼ 5.23% | $2.07$7.35 |
| AMIX Autonomix Medical Inc. Common Stock | $11.82M | — | $2.85 | ▼ 2.90% | $2.44$32.55 |
| OSRH OSR Health Inc. Common Stock | $15.32M | 12.44 | $0.226 | ▲ 13.00% | $0.075$0.9078 |
| MODD Modular Medical Inc. Common Stock | $10.99M | — | $2.32 | ▲ 7.18% | $1.72$18.76 |
| MDAIW Spectral AI Inc. Warrants | $15.91M | — | $0.445 | ▲ 8.54% | $0.355$1.01 |
| ICCM IceCure Medical Ltd. Ordinary Shares | $10.55M | — | $1.06 | ▲ 1.92% | $1.04$29.46 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Steve Mertens · August 28, 2026 · Grant15.0K
- Mark Christianson · August 28, 2026 · Grant12.5K
- David A. Rosa · August 28, 2026 · Grant68.0K
- Johns Emily J. · August 28, 2026 · Grant12.5K
- Volker Christopher · August 28, 2026 · Grant35.0K
- Mark Christianson · June 30, 2026 · Sale10.0K @ $3.18
Institutional Ownership
March 31, 2026
- Total shares held
- 20
- Total value held
- $16
- Institutional holders
- 1
- Unknown20
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
NeuroOne Reports Strong Q4 Sales, New $4.5M Order
NeuroOne Medical Technologies said its Q4 sales were about $3.8 million, up 38% from last year. The company also added a $4.5 million purchase order in September and expects FY26 sales of roughly $10.5 million, a 15.6% increase year‑over‑year. These results come as the share price sits near its 12‑touch support level of $1.63 and an RSI of 45.8.
NeuroOne Reports Strong Q4 Sales, New $4.5M Order. NeuroOne Medical Technologies said its Q4 sales were about $3.8 million, up 38% from last year. The company also added a $4.5 million purchase order in September and expects FY26 sales of roughly $10.5 million, a 15.6% increase year‑over‑year. These results come as the share price sits near its 12‑touch support level of $1.63 and an RSI of 45.8.